SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-23-000729
Filing Date
2023-04-21
Accepted
2023-04-21 16:03:19
Documents
12

Document Format Files

Seq Description Document Type Size
1 REGENERON PHARMACEUTICALS, INC. - DEFA14A lregn2023_defa14a.htm DEFA14A 34137
2 GRAPHIC check01.jpg GRAPHIC 1373
3 GRAPHIC lregn2023_defa14ax1x1.jpg GRAPHIC 49061
4 GRAPHIC lregn2023_defa14ax1x2.jpg GRAPHIC 5163
5 GRAPHIC lregn2023_defa14ax1x3.jpg GRAPHIC 3186
6 GRAPHIC lregn2023_defa14ax1x4.jpg GRAPHIC 7360
7 GRAPHIC lregn2023_defa14ax1x5.jpg GRAPHIC 6871
8 GRAPHIC lregn2023_defa14ax2x1.jpg GRAPHIC 1098
9 GRAPHIC lregn2023_defa14ax2x2.jpg GRAPHIC 1102
10 GRAPHIC lregn2023_defa14ax2x3.jpg GRAPHIC 1093
11 GRAPHIC lregn_logo.jpg GRAPHIC 4392
12 GRAPHIC uncheck.jpg GRAPHIC 1042
  Complete submission text file 0001308179-23-000729.txt   149478
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19034 | Film No.: 23836296
SIC: 2834 Pharmaceutical Preparations